ImmunoTargets and Therapy

ISSN: 2253-1556

Journal Articles:

Review

Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management

Freiha J, Min YG, Osman C, Rajabally YA

ImmunoTargets and Therapy 2026, 15:390161

Published Date: 2 April 2026

Original Research

Deep Learning Classification of Rheumatoid Arthritis in Hand Radiographs Interpretability Insights and Web Application

Cai K, Dou D, Deng G, Zhan Y, Huang H, Feng Z

ImmunoTargets and Therapy 2025, 14:1333-1345

Published Date: 19 November 2025

Review

Research Progress of Natural Killer Cells in Hashimoto’s Thyroiditis

Wang Y, Yan Z, Miao J, Que H, Shan W

ImmunoTargets and Therapy 2025, 14:1029-1040

Published Date: 12 September 2025

Original Research

Conversion of T Effector Cells Into T Regulatory Cells in Type 1 Diabetes/Latent Autoimmune Diabetes of Adults by Inhibiting eIF5A and Notch Pathways

Rafiqi SI, Aldasouqi A, Paparodis RD, Dewan S, Farooqi A, Faisal S, Nemat Y, Salim N, Qureshi S, Mahmood A, Tovar Y, Jun JY, Kalinoski AL, Mirmira RG, Jaume JC, Imam S

ImmunoTargets and Therapy 2025, 14:205-226

Published Date: 13 March 2025

Case report

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report

Zoubi I, Warwar A, Perek S, Preis M

ImmunoTargets and Therapy 2025, 14:1-5

Published Date: 6 January 2025

Review

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery

Ibeanu GC, Rowaiye AB, Okoli JC, Eze DU

ImmunoTargets and Therapy 2024, 13:749-774

Published Date: 13 December 2024

Review

Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

Ferrara CA, La Rocca G, Ielo G, Libra A, Sambataro G

ImmunoTargets and Therapy 2023, 12:79-89

Published Date: 26 July 2023